Werkgroep Cardiologische centra Nederland

SOLOIST-WHF (Recruiting)

A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Effects of SOtagLiflozin on Clinical Outcomes in HemOdynamIcally STable Patients with Type 2 Diabetes POST Worsening Heart Failure
Medicine
sotagliflozin
Population
Heart failure
Phase
III
Starting year
2017